240 related articles for article (PubMed ID: 21633054)
1. Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.
Iima M; Le Bihan D; Okumura R; Okada T; Fujimoto K; Kanao S; Tanaka S; Fujimoto M; Sakashita H; Togashi K
Radiology; 2011 Aug; 260(2):364-72. PubMed ID: 21633054
[TBL] [Abstract][Full Text] [Related]
2. In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.
Rahbar H; Partridge SC; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
Radiology; 2012 May; 263(2):374-82. PubMed ID: 22517955
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast.
Hussein H; Chung C; Moshonov H; Miller N; Kulkarni SR; Scaranelo AM
Acad Radiol; 2015 Dec; 22(12):1483-8. PubMed ID: 26391856
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.
Ei Khouli RH; Jacobs MA; Mezban SD; Huang P; Kamel IR; Macura KJ; Bluemke DA
Radiology; 2010 Jul; 256(1):64-73. PubMed ID: 20574085
[TBL] [Abstract][Full Text] [Related]
5. Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters.
Mori N; Ota H; Mugikura S; Takasawa C; Tominaga J; Ishida T; Watanabe M; Takase K; Takahashi S
Eur Radiol; 2013 Oct; 23(10):2705-12. PubMed ID: 23732688
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.
Kim JY; Kim JJ; Lee JW; Lee NK; Lee G; Kang T; Park H; Son YH; Grimm R
Eur Radiol; 2019 Feb; 29(2):485-493. PubMed ID: 30073498
[TBL] [Abstract][Full Text] [Related]
7. Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging.
Parsian S; Rahbar H; Allison KH; Demartini WB; Olson ML; Lehman CD; Partridge SC
Radiology; 2012 Dec; 265(3):696-706. PubMed ID: 23033500
[TBL] [Abstract][Full Text] [Related]
8. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of minimum apparent diffusion coefficient value in differentiating the invasive breast cancer and ductal carcinoma
Zhao S; Shao G; Chen P; Li L; Yang Y; Zhao X; Guo W
J Cancer Res Ther; 2019; 15(4):871-875. PubMed ID: 31436245
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Park SH; Moon WK; Cho N; Song IC; Chang JM; Park IA; Han W; Noh DY
Radiology; 2010 Oct; 257(1):56-63. PubMed ID: 20851939
[TBL] [Abstract][Full Text] [Related]
11. Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method.
Murakami R; Hirai T; Sugahara T; Fukuoka H; Toya R; Nishimura S; Kitajima M; Okuda T; Nakamura H; Oya N; Kuratsu J; Yamashita Y
Radiology; 2009 Jun; 251(3):838-45. PubMed ID: 19318585
[TBL] [Abstract][Full Text] [Related]
12. Characterization of ductal carcinoma in situ on diffusion weighted breast MRI.
Rahbar H; Partridge SC; Eby PR; Demartini WB; Gutierrez RL; Peacock S; Lehman CD
Eur Radiol; 2011 Sep; 21(9):2011-9. PubMed ID: 21562806
[TBL] [Abstract][Full Text] [Related]
13. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade.
Woo S; Lee JM; Yoon JH; Joo I; Han JK; Choi BI
Radiology; 2014 Mar; 270(3):758-67. PubMed ID: 24475811
[TBL] [Abstract][Full Text] [Related]
14. Quantitative apparent diffusion coefficient as a noninvasive imaging biomarker for the differentiation of invasive breast cancer and ductal carcinoma in situ.
Bickel H; Pinker-Domenig K; Bogner W; Spick C; Bagó-Horváth Z; Weber M; Helbich T; Baltzer P
Invest Radiol; 2015 Feb; 50(2):95-100. PubMed ID: 25333308
[TBL] [Abstract][Full Text] [Related]
15. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors.
Park MJ; Cha ES; Kang BJ; Ihn YK; Baik JH
Korean J Radiol; 2007; 8(5):390-6. PubMed ID: 17923781
[TBL] [Abstract][Full Text] [Related]
16. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.
Kang Y; Choi SH; Kim YJ; Kim KG; Sohn CH; Kim JH; Yun TJ; Chang KH
Radiology; 2011 Dec; 261(3):882-90. PubMed ID: 21969667
[TBL] [Abstract][Full Text] [Related]
17. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging.
Kim S; Jain M; Harris AB; Lee VS; Babb JS; Sigmund EE; Rueff LE; Taouli B
Radiology; 2009 Jun; 251(3):796-807. PubMed ID: 19380690
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
[TBL] [Abstract][Full Text] [Related]
19. Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience.
Zhang J; Tehrani YM; Wang L; Ishill NM; Schwartz LH; Hricak H
Radiology; 2008 May; 247(2):458-64. PubMed ID: 18430878
[TBL] [Abstract][Full Text] [Related]
20. Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient.
Matoba M; Tonami H; Kondou T; Yokota H; Higashi K; Toga H; Sakuma T
Radiology; 2007 May; 243(2):570-7. PubMed ID: 17400757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
